Far More Potent Than THC And CBD: Dr. Raphael Mechoulam Explains His Latest Discovery

Professor Raphael Mechoulam, also known as the “father of cannabis research,” revealed his latest discovery, cannabidiolic acid methyl ester (EPM301), only a few months ago. The introduction of this new, patented compound (synthetic, fully stable acid-based cannabinoid molecules) caused a wave of excitement around the future of medicinal cannabis.

The compound in question was presented to the world in partnership with EPM, a global biotechnology company based in the U.S. that aims to bridge the gap between the cannabis and pharmaceutical industries.

During a recent, exclusive conversation, CEO Reshef Swisa and Dr. Mechoulam, shared the history of the journey behind this revolutionary process and its significance in evolving the use of CBD as a pharmaceutical drug.

Meet EPM301

“EPM developed a method to work with the original substances of cannabis,” the Professor explained. “So, while everybody is discussing THC and CBD, these cannabinoids are actually a secondary substance; they only appear later in the plant.

“Originally there is an acid that appears in the plant, and those acids are these mysterious worlds of compounds that are much more potent than cannabinoids,” he added.

See also: Medical Cannabis Products Formulated For Autism Patients Now Available In Louisiana

However, these cannabidiolic acids were unstable, and therefore useless in pharmaceutical drug development. Until now, that is.

Mechoulam’s recent revelation stems from the development of a method …

Full story available on Benzinga.com

More Far More Potent Than THC And CBD: Dr. Raphael Mechoulam Explains His Latest Discovery